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Peduced Glomerular Filtration
ate in Asymptomatic Diabetic Patients
redictor of Increased Risk for
ardiac Events Independent of Albuminuria
illa Knobler, MD,* Taiba Zornitzki, MD,* Shiraz Vered†, Michael Oettinger, MD,‡ Rosa Levy,‡
braham Caspi, MD,‡ David Faraggi, PHD,† Shay Livschitz, MD‡
ehovot and Haifa, Israel
OBJECTIVES This study aimed to investigate the prevalence of a reduced glomerular filtration rate (GFR)
with and without albuminuria and its ability to predict cardiac events in asymptomatic
diabetic patients undergoing stress-rest thallium-201 myocardial perfusion single-photon
emission computed tomography.
BACKGROUND Diabetic patients have a higher prevalence of asymptomatic coronary heart disease. Therefore,
identifying predictors of cardiac events in asymptomatic diabetic patients is needed.
METHODS In 269 asymptomatic patients, baseline evaluation included diabetes-related complications,
including creatinine clearance (CrCl) and albuminuria. During follow-up (mean 2.3  1.0
years), all cardiac events were recorded.
RESULTS Seventy-seven patients (29%) had a reduced GFR defined by CrCl 60 ml/min/1.73 m2.
Compared with the 177 patients with CrCl 60 ml/min/1.73 m2, the reduced GFR group
was older (p  0.0001), had a longer duration of diabetes (p  0.002), and had a higher
prevalence of albuminuria (p  0.04). Nevertheless, 35% of the reduced GFR group had
normoalbuminuria. Patients with reduced GFR had a significant two-fold increase in total
cardiac events (unstable angina, nonfatal myocardial infarction, and cardiac procedures) (25%
vs. 13%, p  0.019), and multivariate analysis found that reduced GFR was an independent
predictor of cardiac events (odds ratio [OR] 2.2, 95% confidence interval [CI] 1.1 to 4.46).
Other independent predictors of cardiac events included stress-induced abnormal myocardial
perfusion imaging (OR 3.1, 95% CI 1.3 to 7.5), an electrocardiographic ischemic response
(OR 2.7, 95% CI 1.01 to 7.14), and peripheral artery disease (OR 2.1, 95% CI 1.05 to 4.23);
however, albuminuria was not.
CONCLUSIONS A reduced GFR was common in our group of asymptomatic diabetic patients and was
associated with a two-fold increase in cardiac events. Multivariate analysis found that reduced
GFR independent of albuminuria was a significant predictor of cardiac events. (J Am Coll
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.09.006Cardiol 2004;44:2142–8) © 2004 by the American College of Cardiology Foundation
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piabetes mellitus (DM) is associated with a more than
hree-fold increase of coronary artery disease (CAD) (1).
atients with diabetes are often asymptomatic, and the
revalence of silent ischemia diagnosed by noninvasive
echniques ranges from 10% to 30% (2). The American
iabetes Association recommended noninvasive testing in
iabetics with evidence of peripheral artery disease, resting
lectrocardiographic (ECG) abnormalities, or the presence
f additional risk factors (3). However, others have argued
hat there is not enough evidence to perform routine
oninvasive testing in asymptomatic diabetic patients (4),
nd there is a need for further characterization of a high-risk
ubgroup in whom early diagnosis and treatment can reduce
ubsequent cardiac events and improve prognosis.
Several studies in the past have suggested that both
From the *Metabolic Unit, Kaplan Medical Center, affiliated with Hadassah and
he Hebrew University School of Medicine, Rehovot, Israel; †Department of
tatistics, Haifa University, Haifa, Israel; and ‡Institute of Cardiology, Kaplan
edical Center, Rehovot, Israel.f
Manuscript received July 3, 2004; revised manuscript received August 18, 2004,
ccepted September 2, 2004.icroalbuminuria and macroalbuminuria are risk factors for
ardiovascular morbidity and mortality (5,6). These entities
re clinically defined by the urinary albumin excretion rate
r albumin/creatinine ratio (6). In “classic” diabetic ne-
hropathy, after the phase of microalbuminuria, there is a
ontinued increase in urinary albumin excretion with a
eclining glomerular filtration rate (GFR). This phase,
haracterized by macroalbuminuria, relates to the histologic
ndings of glomerulosclerosis and is often accompanied
y diabetic retinopathy. However, the entity of non-
lbuminuric chronic kidney disease, defined by reduced
FR, previously described in the general population, has
ecently emerged as a common and distinct form also in
iabetes (7,8). The pathogenesis of this entity is still
ndetermined; however, atherosclerosis has been suggested
s one possible mechanism (7). Diffuse atherosclerosis may
e the link between chronic kidney disease and cardiovas-
ular mortality and morbidity, as shown by several recent
tudies (9–11). Diabetic patients were included in these
tudies but were not analyzed separately. Moreover, the
redictive value of non-albuminuric chronic kidney disease
or cardiac events in asymptomatic diabetic patients is
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December 7, 2004:2142–8 Reduced GFR and Cardiac Events in Diabeticsnknown. The aims of the present study were to determine
n a group of asymptomatic diabetic patients undergoing
tress-rest thallium (Tl)-201 myocardial perfusion single-
hoton emission computed tomography (SPECT), the
revalence of reduced GFR with and without albuminuria,
s well as the association between baseline reduced GFR
nd subsequent cardiac events.
ETHODS
tudy population and study design. Between January
999 and February 2003, a total of 1,587 diabetic patients
nderwent a stress Tl-201 myocardial perfusion SPECT
tudy in our laboratory at Kaplan Medical Center, a uni-
ersity hospital serving an area of 450,000 people in the
enter of Israel. Among them there were 324 patients who
et the following inclusion criteria: 1) asymptomatic, de-
ned by a lack of chest pain or anginal equivalent, according
o a standard questionnaire administrated on the day of
ardiac testing by the physician performing the test; 2) a
inimum of one-year follow-up. Twenty-two patients were
xcluded due to equivocal perfusion tests, and 33 patients
ere excluded due to a lack of complete clinical or labora-
ory data; 269 patients were included in the final analysis.
his group of 269 patients were referred for perfusion study
ccording to the treating physician’s clinical judgment for
ne or more of the following reasons: risk assessment before
eneral surgery (21%), history of CAD, myocardial infarc-
ion (MI), or angiography demonstrating 50% occlusion
f a coronary artery (47%), abnormal resting ECG (44%),
ncluding MI (14%), and ST-segment changes (30%).
atients were followed for a mean period of 2.3  1.0 years
or occurrence of cardiac events. The follow-up was based
n computerized charts available in our hospital since 1997.
n order to ascertain cardiac outcomes, patients or treating
hysicians were contacted by telephone calls by staff per-
onnel blinded to baseline kidney function. Two patients
ere lost to follow-up. We defined as major cardiac events:
on-fatal MI documented by appropriate cardiac enzyme
evel changes and ECG evidence of acute MI and cardiac
eath determined by a death certificate or hospital record.
inor cardiac events included unstable angina (documented
y in-hospital diagnosis of resting ischemia without evi-
Abbreviations and Acronyms
CAD  coronary artery disease
CI  confidence interval
CrCl  creatinine clearance
CVD  cardiovascular disease
DM  diabetes mellitus
ECG  electrocardiogram/electrocardiographic
GFR  glomerular filtration rate
OR  odds ratio
PVD  peripheral vascular disease
SPECT  single-photon emission computed tomographyence of acute MI) and coronary re-vascularization (either voronary artery bypass graft surgery or percutaneous coro-
ary intervention). Only the first event was used for analysis,
nd in patients who had major and minor events, the major
ardiac event was considered. Total events included major
nd minor cardiac events.
tress and imaging protocol. EXERCISE TEST. Patients
erformed a symptom-limited exercise treadmill test using
he standard Bruce protocol. At near-maximal exercise,
l-201 (3.0 to 3.5 mCi) was injected intravenously with the
ose adjusted for the patient’s weight, and exercise was
ontinued at maximal workload for 1 min.
harmacologic test. Dipyridamole stress was performed in
atients who were unable to perform an exercise stress test.
atients were tested after an overnight fast and discontin-
ation of xanthine-containing products for 24 h before the
est. Intravenous dipyridamole was infused at rate 0.14
g/kg/min during 4 min, up to total dose 0.56 mg/kg,
nder ECG and blood pressure monitoring. Thallium was
njected 4 min later, and scintigraphy was performed after
tress completion.
maging. The SPECT imaging was performed 6 min
fter stress Tl-201. The Tl-201 redistribution imaging was
erformed 3 h after stress imaging. Re-injection of Tl-201
1 mCi) was performed in the presence of a significant stress
erfusion defect immediately after stress SPECT acquisi-
ion. All SPECT studies were acquired on a single-head
amma camera (Elscint Ltd., Haifa, Israel) equipped with a
ow-energy, all-purpose collimator. Images were acquired
sing a continuous mode on a circular orbit over 180° arc,
tarting at the 45° right anterior oblique projection and
nding at the 45° left anterior oblique projection, for a total
f 60 projections at 20 to 25 s per projection. One energy
indow was used, consisting of a 20% windowed centered
n the 70-keV peak. All projections were acquired into a
4  64 image matrix, corrected for non-uniformity, center
f rotation, and patient or organ movement.
linical and ECG responses to stress. During both types
f stress, the 12-lead ECG was recorded each minute and
ontinuously monitored for leads aVF, V1, and V5. Signif-
cant ST-segment depression during the stress test was
efined as 1 mm of horizontal or downsloping or 1.5 mm of
psloping ST-segment depression occurring 80 ms after the
point. The ECG response to stress was categorized as
schemic in the presence of a significant stress-induced
T-segment depression in the absence of ST-T segment
hanges on the baseline ECG. The clinical response to
tress was categorized as ischemic when exercise-induced
ypical angina pectoris or anginal equivalent symptoms
ccurred.
mage interpretation. For each study, a semi-quantitative
isual interpretation of SPECT was performed by dividing
hort-axis and vertical long-axis tomograms into 17 seg-
ents. Each segment was graded with a 5-point scoring
ystem (0  normal, 4  absent uptake). These segments
ere assigned to four evenly spaced regions in distal
entricular, six mid-ventricular, and basal slices of the
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Reduced GFR and Cardiac Events in Diabetics December 7, 2004:2142–8hort-axis views and one apical segment on the mid-
entricular long-axis slice. A summed stress score (SSS) was
btained by adding the scores of the 17 segments of the
tress images. A summed redistribution score (SRS) was
btained by adding the scores of the 17 segments at-rest
mages. The sum of the differences between the stress and
edistribution scores of each of the 17 segments was defined
s the summed difference score (SDS) or reversibility score,
n index of jeopardized myocardium. Image interpretation
as done by physicians blinded to the creatinine clearance
CrCl) and albumin stratification.
linical evaluation. Patients were classified as having di-
betes based on a treating physician’s previous diagnosis
scertained by either treatment for diabetes or fasting
lucose levels 126 mg/dl on two occasions. Baseline CrCl
as calculated by the use of the Cockroft-Gault formula:
40  age (years)  weight (kg)/72  serum creatinine
oncentration (mg/dl)  0.85 if female (12). The formula
as expressed per 1.73 m2 body surface area. Reduced GFR
as defined as CrCl 60 ml/min/1.73 m2. Albumin excre-
ion was based on spot collection and determination of g
lbumin/mg creatinine: normal  30; microalbuminuria
30 to 299; macroalbuminuria  300 (13). Microalbu-
in was determined by immunoturbidimetric assay (Roche
iagnostic GmbH, Mannheim, Germany). In five patients
one in the CrCl 60 ml/min/1.73 m2 group and four in
he CrCl 60 ml/min/1.73 m2 group), urine albumin
easurements were not available. Albuminuria was con-
rmed in 85% of the patients by at least one more urine
pecimen. Urine testing was done 5 to 92 days before or
fter stress test. Clinical data on diabetic complications were
aken from hospital or HMO clinic charts.
tatistical analysis. Data were analyzed with SAS statistical
oftware, version 8 (SAS Institute, Cary, North Carolina), and
 0.05 was considered significant. Continuous variables were
eported as the mean value  SD, and comparisons between
roups were performed using the t test. Categorical data were
ompared by the chi-square test or Fisher exact test whenever
he asymptomatic chi-square test was not appropriate (i.e.,
he excepted value of a cell count was5). The Kaplan-Meier
ethod was used for the survival curves, and curves were
ompared by the log-rank test. The variables included in the
nalysis of predictors for reduced GFR and cardiac events
ere chosen based on previous data and included smok-
ng, hypertension, low-density lipoprotein cholesterol, high-
ensity lipoprotein cholesterol, triglycerides, microalbuminuria
nd macroalbuminuria, usage of beta-blockers, aspirin,
ngiotensin-converting enzyme inhibitors, or angiotensin
eceptor blockers and statins (14). To determine the pre-
ictors of cardiac events, logistic regression analysis was
erformed by the model selection procedure (15). Potential
ariables to be included in the model were identified as the
ariables that were statistically significant (p  0.05).
kaike’s information criteria were used for choosing the
est model (16). mESULTS
aseline characteristics. The study group included 269
atients (173 males and 96 females). The mean age was
6.1  9.6 years, and the mean duration of diabetes was
1.4 8.2 years. There were 77 patients (29%) with at least
oderately reduced GFR (CrCl 60 ml/min/1.73 m2) and
92 patients (71%) without reduced GFR (CrCl 60
l/min/1.73 m2). Baseline characteristics of both groups are
hown in Table 1. Patients with reduced GFR were signif-
cantly older, more of them were women, and their body
ass index was lower. Patients with reduced GFR had a
onger duration of diabetes, but the glycemic control based
n glycosylated hemoglobin (HbA1C) measurements was
imilar. There were no significant differences between the
wo groups in the prevalence of CAD history, hypertension,
moking, and hyperlipidemia.
More patients in the reduced GFR group received insulin
p  0.04). There were no significant differences in the
sage of sulfonylurea and acarbose (54% vs. 53% and 8% vs.
.3%, respectively) and less received metformin (42% vs.
9%, p 0.012), probably due to avoidance of metformin in
atients with impaired renal function. There were no
ignificant differences in the usage of the following medi-
ations between patients with and without reduced GFR:
eta-blockers (62% vs. 67%), aspirin (73% vs. 82%),
ngiotensin-converting enzyme inhibitors or angiotensin
eceptor blockers (70% in both groups), calcium channel
lockers (32% vs. 28%), and statins (66% vs. 65%).
Retinopathy, non-proliferative and proliferative, was
ore common in the reduced GFR group (p  0.034). The
istribution of albumin excretion categories was signifi-
antly different (p  0.04) in patients with and without
aseline reduced GFR. Normoalbuminuria was found in
lmost one-half of the patients without reduced GFR;
owever, normoalbuminuria was also found in a substantial
umber of patients with reduced GFR (35.5%). More
atients in the reduced GFR group had macroalbuminuria,
s compared with the group without reduced GFR (35.5%
s. 21%). Microalbuminuria was found in 29% of the group
ith reduced GFR and 33% of the group without reduced
FR. There were no significant differences in the preva-
ence of peripheral vascular disease (PVD), and peripheral
europathy, defined by the presence of symptoms, occurred
n 55% in the reduced GFR group compared with 47% in
he group without reduced GFR.
Abnormal myocardial perfusion images were similarly
ommon findings in both groups: 65% in the reduced GFR
nd 62% in the group without reduced GFR. There were no
ignificant differences between the two groups in the SSS,
RS, and SDS.
linical outcomes. Patients were followed for a mean
eriod of 2.3  1.0 years. During this period, 44
vents (16%) occurred in the study group, including 32
inor events and 12 major events. Patients with CrCl

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December 7, 2004:2142–8 Reduced GFR and Cardiac Events in Diabetics60 ml/min/1.73 m2 had about two-fold more total events
han did patients with CrCl 60 ml/min/1.73 m2: 25% vs.
3%, p  0.019 (Table 2). Nonfatal MI, unstable angina,
nd percutaneous coronary intervention occurred more of-
en in the reduced GFR group, as compared with the group
ithout reduced GFR; however, these differences did not
each statistical significance. Patients with reduced GFR
ad significantly reduced event-free survival compared with
atients without reduced GFR (p  0.012), demonstrated
y the Kaplan-Meier curve (Fig. 1). There was no statisti-
ally significant difference in the Kaplan-Meier event-free
Table 1. Baseline and Laboratory Characteristi
<60 ml/mi
(n 
Age (yrs) 71.6
Female (%) 45
BMI (kg/m2) 26.9 
Duration of diabetes (yrs) 14.3
Insulin treatment (%) 30
Reasons for referral
History of CAD (%) 49
Abnormal ECG (%) 48
Assessment before surgery (%) 18
Hypertension (%) 88
Smoking (%) 13
PVD (%) 53
Stroke (%) 14
Retinopathy (%) 49
LDL cholesterol (mg/dl) 112 
HDL cholesterol (mg/dl) 44.2
Triglycerides (mg/dl) 186
HbA1c (%) 7.7 
Microalbuminuria* (%) 22 (2
Macroalbuminuria (%) 27 (3
Normoalbuminuria (%) 27 (3
AMPI (%) 65
SSS 9.9
SRS 5.6
SDS 4.3
*In five patients (one in the group of CrCl 60 ml/min/1.7
albumin measurements data were missing. Data are expresse
compared by the chi-square test.
AMPI  abnormal myocardial perfusion imaging; BM
creatinine clearance; ECG  electrocardiogram; HbA1c  g
lipoprotein, respectively; NS not significant; PVD periph
redistribution score; SDS  summed differences score.
Table 2. Cardiac Events in Patients Stratified
Events
<60 ml/min/1.73 m
(n  77)
Total events (%) 19 (25)
Nonfatal MI (%) 6 (9.4)
Unstable angina (%) 6 (9.4)
PCI (%) 6 (9.4)
CABG (%) 1 (1.7)
*Compared by the chi-square test. †Comparisons by the Fis
CABG  coronary artery bypass graft surgery; CrCl  cr
percutaneous coronary intervention.urvival curves stratified by normoalbuminuria and albumin-
ria (data not shown).
Multivariate logistic analysis of predictors of cardiac event
s shown in Table 3. The following parameters were found
o be independent predictors of cardiac events: abnormal
yocardial perfusion imaging (OR [odds ratio] 3.1, 95%
onfidence interval [CI] 1.3 to 7.5), stress-induced ECG
schemic response (OR 2.7, 95% CI 1.01 to 7.14), reduced
FR (OR 2.2, 95% CI 1.1 to 4.46), and PVD (OR 2.1,
5% CI 1.05 to 4.2). Age, history of CAD, smoking, left
entricular function, and microalbuminuria and macroalbu-
ratified by Baseline Creatinine Clearance
CrCl
p Value
3 m2 >60 ml/min/1.73 m2
(n  192)
63.9 9.1  0.0001
32 0.034
29.8 4.3  0.0001
10.3 7.3 0.002
14 0.004
46 NS
42 NS
22 NS
83 NS
20 NS
44 NS
13 NS
35 0.034
110.5 32 NS
43.3 11 NS
192 120 NS
7.9 1.9 NS
62 (33) 0.04
39 (21)
87 (46)
62 NS
10.4 12.0 NS
4.9 8.7 NS
5.4 7.4 NS
nd four in the group of CrCl 60 ml/min/1.73 m2), urine
e mean value  SD or number (%). Categorical data were
ody mass index; CAD  cornary artery disease; CrCl 
ated hemoglobin; HDL and LDL  high- and low-density
ascular disease; SSS summed stress score; SRS summed
aseline Creatinine Clearance
CrCl
p Value
>60 ml/min/1.73 m2
(n  192)
25 (13) 0.019*
6 (3.4) 0.09†
8 (4.5) NS†
7 (4.0) NS†
4 (2.3) NS†
act test. Data are expressed as the number (%) of subjects.cs St
n/1.7
77)
8.5
4.2
9.6
34
12
116
1.6
9)
5.5)
5.5)
11.4
8.0
6.1
3 m2 a
d as th
I  b
lycosylby B
2
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Reduced GFR and Cardiac Events in Diabetics December 7, 2004:2142–8inuria were not found to be independent predictors of
ardiac events.
ISCUSSION
n the current study of asymptomatic diabetic patients who
nderwent stress-rest Tl-201 myocardial perfusion SPECT,
e found that 29% had at least moderately reduced GFR,
efined by CrCl 60 ml/min per 1.73 m2. Among patients
ith reduced GFR, 64% had no macroalbuminuria and 35%
ad no albuminuria (microalbuminuria or macroalbumin-
ria). These findings are consistent with the results of recent
tudies showing that normoalbuminuria is a common find-
ng in patients with type II DM and at least moderately
educed GFR (7,8). Analysis of data from the National
ealth and Nutrition Examination Survey (NHANES III)
howed that 13% of diabetics had moderate reduced GFR
nd 30% of them had no albuminuria or retinopathy (8).
oreover, previous data from the NHANES III showed
hat 20% of diabetics with even more severe chronic kidney
isease (GFR 30 ml/min/1.73 m2) had no albuminuria
17). In another study of 301 outpatients with type II DM,
6% had moderate reduced GFR, and 39% of them were
igure 1. Kaplan-Meier event-free survival curves in patients with and
ithout baseline reduced glomerular filtration rate (p  0.019). Broken
ine  creatinine clearance (CrCl) 60 ml/min/1.73 m2; solid line 
rCl 60 ml/min/1.73 m2.
able 3. Multivariate Analysis of Predictors for Developing
ardiac Events
OR 95% CI p Value
bnormal myocardial perfusion
imaging
3.1 1.3–7.52 0.013
tress ECG ischemic response 2.7 1.01–7.14 0.048
rCl 60 ml/min/1.73 m2 2.2 1.1–4.46 0.026
eripheral vascular disease 2.1 1.05–4.23 0.034
icralbuminuria 0.68 0.35–1.3 NS
acroalbuminuria 0.82 0.41–1.7 NS
ogistic regression analysis of cardiac event predictors. Variables included age, history
f coronary artery disease, smoking, left ventricular function, abnormal stress-induced
lectrocardiographic (ECG), abnormal myocardial perfusion imaging, peripheral
ascular disease, creatinine clearance (CrCl) 60 ml/min/1.73 m2, micro- andm
acroalbuminuria.
CI  confidence interval; OR  odds ratio.ormoalbuminuric (9). All these data imply that chronic
idney disease with normoalbuminuria is a common entity
n type II DM.
The major finding of this study is that reduced GFR was
significant predictor of cardiac events. We found that
iabetics with at least moderately reduced GFR at baseline,
ompared with diabetics without reduced GFR, had an OR
f 2.2 for developing subsequent cardiac events. It was
hown that PVD was an additional significant independent
redictor of cardiac events, whereas albuminuria and reti-
opathy were not. These data provide supportive evidence
hat chronic kidney disease, defined by reduced GFR,
ndependent of albuminuria, is a distinct entity, and the
athogenesis may be different from the classic diabetic
lomerulosclerosis characterized clinically by progressive
lbuminuria and retinopathy (6). Furthermore, the associa-
ion between reduced GFR and increased risk of cardiac
vents suggests that the underlying pathogenesis is related
o atherosclerosis. Studies of diabetic patients with reduced
FR and normoalbuminuria lack data on kidney histology;
owever, atherosclerosis involving renal arteries or smaller-
aliber arteries has been suggested as a possible underlying
rocess (7). In a study of diabetic patients, half of them with
ormoalbuminuria, the GFR correlated with carotid
ntimal-medial thickness and resistance index of renal in-
ralobar arteries, as determined by pulsed Doppler sonog-
aphy (18). The association between cardiovascular disease
CVD) morbidity and mortality and moderate reduction of
FR, in the general population, has been reported recently
9,10,19). In addition, in patients with known cardiac
isease undergoing percutaneous coronary interventions,
ven a moderate reduction of GFR was associated with
ncreased one-year mortality (11,20). These studies included
iabetics but did not analyze them separately nor addressed
he issue of non-albuminuric chronic kidney disease. Our
ndings confirm and extend these findings in the diabetic
opulation. Furthermore, the present study shows that
educed GFR predicted cardiac events, independent of the
resence and severity of albuminuria.
An association between microalbuminuria and mac-
oalbuminuria and CVD morbidity and mortality has been
hown by several studies (5,19,21,22). The difference be-
ween our results and previous data can be related to
ifferences in study populations and design. Our patients
ere relatively old and many of them had evidence of CVD
t baseline. Interestingly, in a study that evaluated long-
erm mortality of diabetic patients, the value of urinary
lbumin excretion disappeared, suggesting that albuminuria
ay be a stronger risk factor for CVD in the short term
23). In addition, most previous studies did not analyze the
FR, a more accurate measurement of renal function than
erum creatinine. Further studies that will include both
rine albumin measurements and renal function estimation
by simple measures, such as the Cockroft-Gault formula),
ay be useful in dissecting the prognostic contribution of
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ifferent subgroups of diabetic patients.
In the current study, despite the fact that patients with
educed GFR had a similar baseline prevalence of CAD and
VD, as the group without reduced GFR, they developed
ignificantly more cardiac events. Moreover, this increased
isk was not explained by the traditional risk factors. These
ntriguing findings are in accordance with recent data
uggesting that patients with chronic kidney disease have
ther nontraditional risk factors contributing to the excess
isk of cardiac events (14). These factors include endothelial
ysfunction, oxidative stress, inflammation, and increased
oagulation, which can lead to increased risk of plaque
apture and increased risk of arrhythmias (14,19). All of
hese data are consistent with the current recommendation
f the National Kidney Foundation that patients with
hronic kidney disease should be considered in the highest
isk group for cardiovascular diseases (24). Further inter-
ention studies are needed to determine whether different
herapeutic modalities, including intensive control of both
raditional and nontraditional risk factors for CAD, alter
he unfavorable clinical course of diabetic patients with
educed GFR.
Our study included asymptomatic diabetic patients who
nderwent Tl-201 myocardial perfusion SPECT. Previous
tudies using noninvasive tests found that the prevalence of
ilent ischemia was between 10% and 30% (2). In our study,
he prevalence of abnormal myocardial perfusion imaging
bnormalities was even higher. This high prevalence can be
ue to the baseline characteristics of our study group, which
ncluded a substantial number of patients with a history of
AD and PVD. During follow-up, 16% developed cardiac
vents, and both stress-induced ECG ischemic response
nd abnormal myocardial perfusion imaging were indepen-
ent predictors of events. Most previous studies of asymp-
omatic diabetic patients also showed that abnormal myo-
ardial scintigraphy is a strong independent predictor of
ardiac events (25–27). However, one study of 120 asymp-
omatic diabetic patients found that silent ischemia diag-
osed by noninvasive testing was only weakly associated
ith cardiac events, whereas cardiac autonomic neuropathy
as a significant independent predictor (28). Nevertheless,
0% of patients in this study who had both silent ischemia
nd cardiac autonomic neuropathy developed events. The
ontribution of cardiac autonomic neuropathy could not be
ssessed in the current study due to the lack of standard
esting, but there was no difference in the prevalence of
eripheral neuropathy, which was high in both groups, and
ften accompanies autonomic neuropathy. Other predictors
ound in previous studies included coronary stenosis, pe-
ipheral or carotid occlusive arterial disease, diabetes dura-
ion, and retinopathy (25–27). Based on our data and
revious studies, noninvasive testing (i.e., stress-induced
CG and myocardial perfusion test) has an important role
n assessing cardiac risk in asymptomatic diabetic patients.
owever, routine usage of these noninvasive tests in alliabetic patients is still a controversial issue due to uncer-
ainties regarding the clinical benefit of early intervention
nd cost-effectiveness (4). Additional markers that identify
igh-risk patients can lead to better selection of patients
ho would benefit from noninvasive testing. Our data
uggest that reduced GFR, independent of albuminuria, is
n important predictor of cardiac events and should be
earched for in the routine assessment of diabetic patients.
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f Metabolic Unit, Kaplan Medical Center, Rehovot, Israel 76100.
-mail: knobler@inter.net.il.
EFERENCES
1. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk
factors, and 12-yr cardiovascular mortality for men screened in the
Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434–
44.
2. Navare SM, Heller GV. Role of stress single-photon emission com-
puted tomography imaging in asymptomatic patients with diabetes.
Am Heart J 2004;147:753–5.
3. American Diabetes Association. Consensus development conference
on the diagnosis of coronary heart disease in people with diabetes.
Diabetes Care 1998;21:1551–9.
4. Grundy SM, Garber A, Goldberg R, et al. Prevention Conference VI:
diabetes and cardiovascular disease. Writing Group IV: lifestyle and
medical management of risk factors. Circulation 2002;105:153–8.
5. Dinneen SF, Gerstein HC. The association of microalbuminuria and
mortality in non–insulin-dependent diabetes mellitus: a systematic
overview of the literature. Arch Intern Med 1997;157:1413–8.
6. Cooper ME. Pathogenesis, prevention and treatment of diabetic
nephropathy. Lancet 1998;352:213–9.
7. Kramer HJ, Nguyen QD, Curhan G, Hsu C. Renal insufficiency in the
absence of albuminuria and retinopathy among adults with type 2
diabetes mellitus. JAMA 2003;289:3273–7.
8. MacIsaac RJ, Tsalamandris C, Panagiotopoulos S, Smith TJ, McNeil
KJ, Jerums G. Nonalbuminuric renal insufficiency in type 2 diabetes.
Diabetes Care 2004;27:195–200.
9. Henry RMA, Kostense PJ, Bos G, et al. Mild renal insufficiency is
associated with increased cardiovascular mortality: the Hoorn Study.
Kidney Int 2002;62:1402–7.
0. Rahman M, Brown CD, Coresh J, et al. The prevalence of reduced
glomerular filtration rate in older hypertensive patients and its associ-
ation with cardiovascular disease. Arch Intern Med 2004;164:969–76.
1. Sadeghi HM, Stone GW, Grines CL, et al. Impact of renal insuffi-
ciency in patients undergoing primary angioplasty for acute myocardial
infarction. Circulation 2003;108:2769–75.
2. Cockroft DW, Gault MH. Prediction of creatinine clearance from
serum creatinine. Nephron 1976;16:31–41.
3. American Diabetes Association. Position statements: nephropathy in
diabetes. Diabetes Care 2004;27:S79–83.
4. McCullough PA. Cardiorenal risk: an important clinical intersection.
Rev Cardiovasc Med 2002;3:71–6.
5. Collett D. Modeling Binary Data. London: Chapman and Hall, 1991.
6. Cnaan A, Laird NM, Slasor P. Using the general linear mixed model
to analyse unbalanced repeated measures and longitudinal data. Statist
Med 1997;16:2349–80.
7. Garg AX, Kiberd BA, Clark WF, Haynes RB, Clase CM. Albumin-
uria and renal insufficiency prevalence guides population screening:
results from the NHANES III. Kidney Int 2002;61:2165–75.
8. Taniwaki H, Nishizawa Y, Kawagishi T, et al. Decrease in glomerular
filtration rate in Japanese patients with type 2 diabetes is linked to
atherosclerosis. Diabetes Care 1998;21:1848–55.
9. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk
factor for development of cardiovascular disease. A statement from the
American Heart Association Councils on Kidney in Cardiovascular
Disease, High Blood Pressure Research, Clinical Cardiology, and
Epidemiology and Prevention. Circulation 2003;108:2154–69.
22
2
2
2
2
2
2
2
2148 Knobler et al. JACC Vol. 44, No. 11, 2004
Reduced GFR and Cardiac Events in Diabetics December 7, 2004:2142–80. Best PJ, Lennon R, Ting HH, et al. The impact of renal insufficiency
on clinical outcomes in patients undergoing percutaneous coronary
intervention. J Am Coll Cardiol 2002;39:1113–9.
1. Stiegler H, Standl E, Schulz K, Roth R, Lehmacher W. Morbidity,
mortality, and albuminuria in type 2 diabetic patients: a three-year
prospective study of random cohort in general practice. Diabet Med
1992;9:646–53.
2. Mattock MB, Morrish NJ, Viberti G, Keen H, Fitzgerald AP, Jackson
G. Prospective study of microalbuminuria as predictor of mortality in
NIDDM. Diabetes 1992;41:736–41.
3. Damsgaard EM, Froland A, Jorgensen OD, Morgensen CE. Prog-
nostic value of urinary albumin excretion rate and other risk factors in
elderly diabetic patients and non-diabetic control subjects surviving the
first 5 years after assessment. Diabetologia 1993;36:1030–6.
4. Kidney Disease Outcomes Quality Initiative (K/DOQI) Group.
K/DOQI clinical practice guidelines for management of dyslipidemias
in patients with chronic kidney disease. Am J Kidney Dis 2003;41
Suppl 3:S1–91.5. De Lorenzo A, Lima RSL, Siqueira-Filho AG, Pantoja MR. Preva-
lence and prognostic value of perfusion defects detected by stress
technetium-99m sestamibi myocardial perfusion single-photon emis-
sion computed tomography in asymptomatic patients with diabetes
mellitus and no known coronary artery disease. Am J Cardiol 2002;
90:827–32.
6. Cosson E, Paycha F, Paries J, et al. Detecting silent coronary
stenosis and stratifying cardiac risk in patients with diabetes: ECG
stress test or exercise myocardial scintigraphy? Diabet Med 2004;
21:342– 8.
7. Faglia E, Favales F, Calia P, et al. Cardiac events in 735 type 2 diabetic
patients who underwent screening for unknown asymptomatic coro-
nary artery disease: 5-years follow-up report from the Milan Study on
Atherosclerosis and Diabetes (MiSAD). Diabetes Care 2002;25:
2032–6.
8. Valensi P, Regis-Nessim S, Harfouche B, et al. Predictive value of
cardiac autonomic neuropathy in diabetic patients with or without
silent myocardial ischemia. Diabetes Care 2001;24:339–43.
